https://www.oncologynurseadvisor.com Sat, 14 Oct 2023 03:00:44 +0000 en-US hourly 1 https://wordpress.org/?v=6.4.3 https://www.oncologynurseadvisor.com/wp-content/uploads/sites/13/2024/01/cropped-CTA-ONA-HEM-favicon-32x32.png https://www.oncologynurseadvisor.com 32 32 https://www.oncologynurseadvisor.com/home/cancer-types/general-oncology/covid19-pandemic-drug-shortages-cancer-care/ Tue, 30 Aug 2022 14:40:00 +0000 https://www.oncologynurseadvisor.com/?p=101532 Experts discuss current and potential future shortages affecting the oncology field as well as strategies for preventing and managing shortages. ]]> https://www.oncologynurseadvisor.com/home/cancer-types/general-oncology/lack-of-mask-mandates-leaves-cancer-patients-feeling-unprotected/ Wed, 13 Jul 2022 15:00:00 +0000 https://www.cancertherapyadvisor.com/?p=127311 Cancer patients have voiced concerns about a lack of masking at cancer centers and have reported being harassed for wearing masks in public.]]> https://www.oncologynurseadvisor.com/home/cancer-types/general-oncology/cancer-specific-death-risk-may-remain-elevated-30-years/ Thu, 12 May 2022 14:45:00 +0000 https://www.oncologynurseadvisor.com/?p=99010 Patients with certain cancers have an increased risk of cancer-specific mortality that persists for 30 to 35 years after diagnosis.]]> https://www.oncologynurseadvisor.com/home/cancer-types/gastrointestinal-cancer/gastrointestinal-survival-benefit-absent-high-cost-therapies/ Thu, 28 Jan 2021 12:00:01 +0000 https://www.oncologynurseadvisor.com/?p=89172 Investigators assessed disparities in patient access to therapies approved for the treatment of gastrointestinal malignancies in the United States, the United Kingdom, Europe, and Ireland, as well as benefit relative to cost.]]> https://www.oncologynurseadvisor.com/home/cancer-types/gastrointestinal-cancer/hepatocellular-cancer-hcc-reflect-study-lenvatinib-treatment-risk/ Tue, 19 Jan 2021 13:00:28 +0000 https://www.oncologynurseadvisor.com/?p=88927 Outcomes of lenvatinib-receiving patients who progressed to Child-Pugh B liver function within the first 8 weeks of treatment were compared with those of patients who maintained Child-Pugh A classification during the same time period. ]]> https://www.oncologynurseadvisor.com/home/cancer-types/ovarian-cancer/american-cancer-society-cervical-screening-guidelines-update/ Wed, 16 Sep 2020 16:36:57 +0000 https://www.cancertherapyadvisor.com/?p=94625 New guidelines from the American Cancer Society (ACS) appear to move away from the reliance on cytology screening via Pap testing.]]> https://www.oncologynurseadvisor.com/home/cancer-types/multiple-myeloma/covid19-coronavirus-multiple-myeloma-tocilizumab-shows-benefit-treatment/ Thu, 14 May 2020 15:31:02 +0000 https://www.oncologynurseadvisor.com/?p=79645 IL-6 blockade may have helped a patient with multiple myeloma recover from COVID-19, but larger studies are needed to prove efficacy.]]> https://www.oncologynurseadvisor.com/home/cancer-types/genitourinary-cancer/urothelial-cancer-combo-therapy-shows-promise-early-clinical-trial/ Tue, 25 Feb 2020 14:44:05 +0000 https://www.oncologynurseadvisor.com/?p=76542 A combination of pembrolizumab and an antibody-drug conjugate demonstrated a 73% overall response rate in a phase 1/2 clinical trial.]]>